$OMDA

Gracey Craig sold $40K of OMDA

Gracey Craig (Chief Accounting Officer) sold 2,083 shares of Omada Health, Inc. (OMDA) at $19.01 on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 26, 2026, 11:04 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 11:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
medium confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure updates the insider’s post-transaction holdings (5,025 shares) but does not indicate a change in company fundamentals or guidance.

02

Market read

Traders may monitor insider activity, but this specific transaction is likely low-signal due to the 10b5-1 structure and modest size.

03

What to watch

The filing date is later than the trade date; any short-term sentiment impact should be weighed against the fact the sale already occurred on 6/24.

Relevance 2/10Novelty 5/10Timing: filed 2026-06-26 after-hours; sale executed 2026-06-24

Background

SEC Form 4 reports an officer’s open-market sale executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralMedium confidence
Context

Omada Health CFO Gracey Craig sold 2,083 shares on 2026-06-24 under a pre-arranged 10b5-1 plan, disclosing $39,601.58 proceeds.

Expected impact

Low likelihood of a sustained price move; any near-term reaction is likely muted and quickly absorbed.

Evidence & confidence

Form 4 is a primary disclosure, but the transaction is explicitly under a pre-arranged 10b5-1 plan and the dollar amount is modest relative to typical market moves.

Market effects

Minimal; this is company-specific insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because it’s a 10b5-1 sale, the disclosure may be mechanically scheduled rather than information-bearing; traders may discount it entirely.

Key entities

  • Omada Health, Inc.

    Company whose CFO insider sale is disclosed on Form 4.

  • Gracey Craig

    Chief Accounting Officer who sold shares under a 10b5-1 plan.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom